β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]
PLoS ONE, 2014 Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça +9 more
doaj +1 more source
Nucleic acids enrichment of fungal pathogens to study host-pathogen interactions [PDF]
, 2019 Fungal infections, ranging from superficial to life-threatening infections, represent a major public health problem that affects 25% of the worldwide population.
Coucke, Paul +3 more
core +1 more source
Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. [PDF]
PLoS ONE, 2018 OBJECTIVE:To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN:Cross-sectional study.
José Marcos Sanches +8 more
doaj +1 more source
Clinical case: patient treated for vulvovaginal candidiasis
Клинический разбор в общей медицине, 2021 Case study of acute vulvovaginal candidiasis treated with medication containing dequalinium chloride as an active ingredient has been reported. Patient A.
Tatyana Yu. Pestrikova
doaj +1 more source
A tale of two yeasts : Saccharomyces cerevisiae as a therapeutic against candidiasis [PDF]
, 2016 Funding DW is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (102549/Z/13/Z), a Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology (097377/Z/11/Z), the MRC and University of ...
Wilson, Duncan
core +1 more source
Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy [PDF]
РМЖ. Мать и дитя, 2018 Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.
Kan N.E., Lomova N.A., Kokoeva D.N.
doaj
Non-albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11, CDR1, CDR2, and MDR1 Genes. [PDF]
MicrobiologyopenThe rise in azole resistance among Nakaseomyces glabratus and Pichia kudriavzevii presents a growing public health challenge. These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.
Ranjbar Golafshani FZ +3 more
europepmc +2 more sources
Candida albicans pathogenicity mechanisms [PDF]
, 2013 Peer reviewedPublisher ...
Alonso-Monge R +10 more
core +1 more source
Topical treatment for acute vulvovaginal candidiasis [PDF]
РМЖ. Мать и дитя, 2019 Topical treatment for acute vulvovaginal candidiasis V.G. Volkov Tula State University, Tula, Russian Federation Vulvovaginal candidiasis is a yeast infection of vulvar and vaginal mucosa caused by Candida species.
Volkov V.G.
doaj
Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj +1 more source